Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes Chairman / CEO gave up 41,723 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP & General Manager US gave up 7,695 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, GMAPPS gave up 5,706 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 6,870 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP & Chief Medical Officer gave up 8,316 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, Human Resources gave up 5,560 shares (to pay taxes)
  7. 4 Shares withheld for taxes Principal Accounting Officer gave up 844 shares (to pay taxes)
  8. 4 Grant or award Director acquired 1,074 shares (grant or award)
  9. 4 Grant or award Director acquired 399 shares (grant or award)
  10. 4 Grant or award Director acquired 409 shares (grant or award)
  11. 4 Returned to the company Director returned 5,459,183 shares (to the company)
  12. 4 Planned sale EVP & General Manager US sold 19,164 shares at $60.00 ($1,149,840)
  13. 4 Grant or award Director acquired 2,830 shares (grant or award)
  14. 4 Grant or award Director acquired 2,830 shares (grant or award)
  15. 4 Grant or award Director acquired 2,830 shares (grant or award)
  16. 4 Grant or award Director acquired 2,830 shares (grant or award)
  17. 4 Shares withheld for taxes Director gave up 752 shares (to pay taxes)
  18. 4 Grant or award Director acquired 2,830 shares (grant or award)
  19. 4 Grant or award Director acquired 2,830 shares (grant or award)
  20. 4 Planned sale Principal Accounting Officer sold 1,093 shares at $58.91 ($64,389)

Page 12 of 82 · 1,628 filings